ACTRN12626000938303进行中（未招募）不适用
A randomised controlled trial of an AI-enhanced, skills-based psychosocial app for posttraumatic stress symptoms in regional and rural Australia
Phoenix Australia – Centre for Posttraumatic Mental Health0 个研究点目标入组 650 人开始时间: 2026年8月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 650
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 No limit（—）
- 性别
- All
入选标准
- •Aged 18 years or older
- •Lives or works in a regional, rural, or remote Australian community, or has strong family, community, or personal ties to one
排除标准
- •No exclusion criteria other than failure to meet the inclusion criteria
研究者
相似试验
进行中（未招募）
不适用
A pilot study comparing a co-designed patient information leaflet with a standard leaflet for care after a heart attackPost-myocardial infarction careCirculatory SystemISRCTN10966785University College Cork100
进行中（未招募）
不适用
A trial examining the feasibility, acceptability and efficacy of a psychologist-supported digital program for anxiety and risky drinking in mothersRisky drinkingMental Health - AddictionMental Health - AnxietyMental Health - DepressionAnxietyDepressionACTRN12626000834358The University of Sydney130
进行中（未招募）
2 期
A study to evaluate the tolerability and the effects on the immune system of a tetanus and diphtheria vaccine which does not need any cold chain distribution or storageTetanus and diphtheria preventative vaccinationInfections and InfestationsISRCTN17148628Stablepharma Ltd160
已完成
1 期
A randomised, placebo-controlled, double-blinded, cross-over, Phase 1 study evaluating the safety and preliminary efficacy of the GLP 1 analogue ROSE-010 on appetite and food intake in overweight and obese subjects.Obesity2023-507758-34-00Rose Pharma Inc.12
进行中（未招募）
1 期
A 4-week, first in human study assessing the safety and tolerability of different doses of oral insulin (EA-Ins-IQ-100) in healthy volunteersMetabolic and Endocrine - DiabetesType 1 DiabetesACTRN12626000827336Endo Axiom Pty Ltd12